HCP, Inc. (NYSE:HCP) was upgraded by Mizuho from a “neutral” rating to a “buy” rating in a report issued on Thursday.

Several other research firms have also weighed in on HCP. Bank of America Corporation lowered shares of HCP from a “buy” rating to a “neutral” rating and reduced their price target for the company from $33.00 to $31.00 in a research report on Friday, September 22nd. Morgan Stanley reduced their price target on shares of HCP from $31.00 to $29.00 and set an “equal weight” rating for the company in a research report on Monday, September 25th. Zacks Investment Research lowered shares of HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Stifel Nicolaus restated a “hold” rating and set a $31.00 price target on shares of HCP in a research report on Friday, July 14th. Finally, Goldman Sachs Group, Inc. (The) lowered shares of HCP from a “buy” rating to a “neutral” rating and reduced their price target for the company from $35.00 to $32.00 in a research report on Monday, July 24th. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $30.98.

HCP (NYSE:HCP) last posted its earnings results on Monday, October 30th. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.17 by $0.31. HCP had a net margin of 32.16% and a return on equity of 9.96%. The firm had revenue of $454.00 million during the quarter, compared to analyst estimates of $440.60 million. During the same quarter in the prior year, the business posted $0.72 EPS. The business’s revenue was down 14.4% compared to the same quarter last year.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://theolympiareport.com/2017/11/02/hcp-inc-hcp-rating-increased-to-buy-at-mizuho.html.

Several institutional investors have recently made changes to their positions in HCP. Royal Bank of Canada lifted its holdings in shares of HCP by 353.7% in the second quarter. Royal Bank of Canada now owns 1,826,053 shares of the real estate investment trust’s stock worth $58,362,000 after buying an additional 1,423,582 shares in the last quarter. Cbre Clarion Securities LLC lifted its holdings in shares of HCP by 18.1% in the second quarter. Cbre Clarion Securities LLC now owns 9,223,958 shares of the real estate investment trust’s stock worth $294,798,000 after buying an additional 1,413,760 shares in the last quarter. APG Asset Management US Inc. lifted its holdings in shares of HCP by 43.8% in the second quarter. APG Asset Management US Inc. now owns 3,458,000 shares of the real estate investment trust’s stock worth $110,518,000 after buying an additional 1,052,882 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of HCP by 48.1% in the second quarter. Russell Investments Group Ltd. now owns 2,300,224 shares of the real estate investment trust’s stock worth $73,534,000 after buying an additional 747,024 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of HCP by 6.9% in the second quarter. Daiwa Securities Group Inc. now owns 10,610,722 shares of the real estate investment trust’s stock worth $339,119,000 after buying an additional 687,228 shares in the last quarter. 89.73% of the stock is currently owned by hedge funds and other institutional investors.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.